Suppr超能文献

联合共识临床标准和SNRPN基因分子标记对泰国患者普拉德-威利综合征诊断的最高准确性。

Highest accuracy of combined consensus clinical criteria and SNRPN gene molecular markers in diagnosis of Prader-Willi syndrome in Thai patients.

作者信息

Promkan Moltira, Teingtat Somporn, Stheinkijkarnchai Atchara, Wasant Pornswan, Patmasiriwat Pimpicha

机构信息

Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Bangkok, Thailand.

出版信息

Clin Chem Lab Med. 2007;45(8):972-80. doi: 10.1515/CCLM.2007.271.

Abstract

BACKGROUND

Prader-Willi Syndrome (PWS) is a complex human genetic disease arising from a loss of paternal allele expression of imprinting genes on chromosome 15q11-q13. Normally the CpG islands at this site are heavily methylated in the maternal allele, but unmethylated in the paternal allele and therefore activated in gene expression. only the methylated allele should present in pws patients when methylation-specific pcr (msp) is analyzed.

METHODS

This paper reports an analysis of PWS in Thai patients using consensus diagnostic criteria based on a combination of clinical data, basic G-banding and fluorescence in situ hybridization (FISH) cytogenetics, PCR-based methylation assay, and bisulfite sequencing of the CpG islands of SNRPN to confirm 15q deletion or the methylation pattern of the SNRPN promoter and exon 1. Lack of complete clinical reports or inadequacy of the minimum laboratory support required had made it difficult to diagnose PWS, Angelman syndrome and other microdeletion disorders.

RESULTS

Accuracy of 100% was obtained for diagnosis of the PWS study patients using the minimum requirements necessary. A total of 20 patients were diagnosed as PWS based on clinical criteria and the scoring tool for PWS, and the same approach was applied to four separate patients with some unmatched criteria but phenotypic similarity to PWS. Findings showed that 70% of those clinically diagnosed as PWS patients (14/20) had a deletion at 15q11-q13 according to FISH, while all 20 patients showed MSP positive of SNRPN gene. Six cases (30%) without a paternal deletion were confirmed to have maternal uniparental disomy (mUPD) of PWS by MSP and methylation sequencing approaches. Noteworthy, two of the six cases with mUPD were 3.5 year-old twins. None of the five cases with scores lower than the reported consensus criteria showed positive G-band, FISH or MSP results.

CONCLUSIONS

We demonstrate here the high power of combining clinical findings, FISH and MSP in definitive diagnosis of PWS and in distinguishing between the two major different types of molecular mechanisms. No false positives or false negatives were observed in our analysis.

摘要

背景

普拉德-威利综合征(PWS)是一种复杂的人类遗传疾病,由15号染色体q11-q13区域印记基因的父本等位基因表达缺失引起。正常情况下,该位点的CpG岛在母本等位基因中高度甲基化,但在父本等位基因中未甲基化,因此在基因表达中被激活。在分析甲基化特异性PCR(msp)时,pws患者中应仅出现甲基化等位基因。

方法

本文报告了对泰国患者的PWS分析,采用基于临床数据、基本G显带和荧光原位杂交(FISH)细胞遗传学、基于PCR的甲基化检测以及对SNRPN的CpG岛进行亚硫酸氢盐测序的共识诊断标准,以确认15q缺失或SNRPN启动子和外显子1的甲基化模式。由于缺乏完整的临床报告或所需的最低实验室支持不足,使得诊断PWS、天使综合征和其他微缺失疾病变得困难。

结果

使用必要的最低要求对PWS研究患者进行诊断,准确率达到100%。共有20例患者根据临床标准和PWS评分工具被诊断为PWS,同样的方法应用于另外4例有一些不匹配标准但与PWS表型相似性的患者。结果显示,根据FISH,临床诊断为PWS患者的70%(14/20)在15q11-q13区域有缺失,而所有20例患者的SNRPN基因的MSP检测均为阳性。通过MSP和甲基化测序方法,6例(30%)无父本缺失的患者被确认为PWS的母本单亲二倍体(mUPD)。值得注意的是,6例mUPD患者中有2例是3.5岁的双胞胎。5例评分低于报告的共识标准的患者,其G显带、FISH或MSP检测结果均为阴性。

结论

我们在此证明了结合临床发现、FISH和MSP在PWS的明确诊断以及区分两种主要不同分子机制方面的强大作用。在我们的分析中未观察到假阳性或假阴性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验